Roche Spends $570M on Another ADC Agreement With China’s MediLink

Roche first partnered with MediLink in January 2024, likewise for an antibody-drug conjugate for solid tumors.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top